Atorvastatin Calcium Tablet
Product Images NDC 71335-2213

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 1)

A line graph depicting cumulative incidence over a period of 3.5 years. Two lines compare Atorvastatin versus Placebo, with Atorvastatin showing a lower cumulative incidence. The graph includes hazard ratio (HR=0.64) with confidence interval and a p-value of 0.0005, indicating statistical comparison between the two groups.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 2)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint over four years of follow-up, and the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a consistently lower cumulative hazard than the placebo group, with hazard ratio and p-value noted on the graph.*

FDA Label Image

Image Description (Atorvastat Cal Usp Fig 3)

A line graph showing the cumulative percentage of subjects experiencing a major cardiovascular event over five years for two dosages of Atorvastatin: 10 mg and 80 mg. The y-axis represents the percentage of subjects experiencing the event, and the x-axis shows time to first major cardiovascular endpoint in years. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval of 0.69 to 0.89 and a p-value of 0.0002, indicating statistical significance.*

FDA Label Image

Image Description (Atorvastat Cal Usp Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including phenyl groups, fluorophenyl, hydroxyl groups, and calcium ion complexation depicted in the formula.*

FDA Label Image

Label (Lbl713352213)

Atorvastatin Calcium Tablets, USP 20 mg oral tablet label shows the NDC 71335-2213-1 and contains 30 tablets. The label includes storage instructions, a QR code, and states the product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Umedica Laboratories Pvt. Ltd. The strength 20 mg is highlighted clearly on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.